Estrogen inhibition of EAE involves effects on dendritic cell function

Estrogen has been found to have suppressive effects on the induction of experimental autoimmune encephalomyelitis (EAE), an animal model for the human disease multiple sclerosis. We have investigated the effects of 17β‐estradiol (E2) treatment on dendritic cells (DCs) in two different mouse models of EAE. The frequency of CD11b+/CD11c+ DCs was significantly decreased in the brain of mice protected from EAE induction by E2 treatment. In addition, the frequency of CD11c+/CD8α+ DCs producing tumor necrosis factor (TNF)α and interferon (IFN)γ in the spleen of E2‐treated mice was dramatically decreased compared to that in control mice with EAE, demonstrating an effect of E2 on DC function. In order to examine E2 effects on DCs in more detail, splenic DCs were cultured in the presence of granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) and interleukin (IL)‐4to promote maturation. E2 pretreatment was found to suppress the ability of cultured DCs bearing a mature phenotype to present Ag to myelin basic protein (MBP)‐specific T cells. Analysis of cytokine production demonstrated that E2 decreased TNFα, IFNγ and IL‐12 production in mature DCs. In addition, MBP‐specific T cells cocultured with E2‐pretreated mature DCs in the presence of antigen demonstrated a shift towards production of Th2 cytokines IL‐4 and IL‐10 and a concomitant decrease in the production of Th1 cytokines TNFα and IFNγ. Thus, E2 treatment appears to have multiple effects on the DC population, which may contribute to a down‐regulation or block in the activation of Th1 cells involved in the induction of EAE. © 2002 Wiley‐Liss, Inc.

[1]  R. Maldonado-López,et al.  Cytokines Regulate the Capacity of CD8α+ and CD8α− Dendritic Cells to Prime Th1/Th2 Cells In Vivo1 , 2001, The Journal of Immunology.

[2]  Shigeo Koyasu,et al.  IFN-γ production by antigen-presenting cells: mechanisms emerge , 2001 .

[3]  A. Vandenbark,et al.  17β‐estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis , 2001 .

[4]  J. Reimann,et al.  IL-12/IL-18-Dependent IFN-γ Release by Murine Dendritic Cells1 , 2001, The Journal of Immunology.

[5]  A. Enk,et al.  Dendritic cells as a tool to induce anergic and regulatory T cells. , 2001, Trends in immunology.

[6]  H. Offner,et al.  Estrogen Treatment Down-Regulates TNF-α Production and Reduces the Severity of Experimental Autoimmune Encephalomyelitis in Cytokine Knockout Mice1 , 2001, The Journal of Immunology.

[7]  R. Maldonado-López,et al.  CD8α− and CD8α+ subclasses of dendritic cells undergo phenotypic and functional maturation in vitro and in vivo , 2001, Journal of Leukocyte Biology.

[8]  P. Hertzog,et al.  Differential Production of IL-12, IFN-α, and IFN-γ by Mouse Dendritic Cell Subsets1 , 2001, The Journal of Immunology.

[9]  G. Reichmann,et al.  Brain Dendritic Cells and Macrophages/Microglia in Central Nervous System Inflammation1 , 2001, The Journal of Immunology.

[10]  A. Vandenbark,et al.  Low-Dose Estrogen Therapy Ameliorates Experimental Autoimmune Encephalomyelitis in Two Different Inbred Mouse Strains1 , 2001, The Journal of Immunology.

[11]  I. Weissman,et al.  Development of CD8α-Positive Dendritic Cells from a Common Myeloid Progenitor , 2000 .

[12]  B. Serafini,et al.  Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis. , 2000, The American journal of pathology.

[13]  A. Dietz,et al.  Maturation of human monocyte-derived dendritic cells studied by microarray hybridization. , 2000, Biochemical and biophysical research communications.

[14]  G. Schuler,et al.  Immature dendritic cells generated with low doses of GM‐CSF in the absence of IL‐4 are maturation resistant and prolong allograft survival in vivo , 2000, European journal of immunology.

[15]  A. Vandenbark,et al.  Estrogen potentiates treatment with T-cell receptor protein of female mice with experimental encephalomyelitis. , 2000, The Journal of clinical investigation.

[16]  P. Kalinski,et al.  Development of Th1-Inducing Capacity in Myeloid Dendritic Cells Requires Environmental Instruction1 , 2000, The Journal of Immunology.

[17]  O. Lassila,et al.  Nonsteroidal anti-estrogens inhibit the functional differentiation of human monocyte-derived dendritic cells. , 2000, Blood.

[18]  L. Lu,et al.  Chemokine and chemokine receptor expression by liver-derived dendritic cells: MIP-1alpha production is induced by bacterial lipopolysaccharide and interaction with allogeneic T cells. , 2000, Transplant immunology.

[19]  A. Thomson,et al.  Effects of Liver-Derived Dendritic Cell Progenitors on Th1- and Th2-Like Cytokine Responses In Vitro and In Vivo1 , 2000, The Journal of Immunology.

[20]  P. Allavena,et al.  Differential responsiveness to constitutive vs. inducible chemokines of immature and mature mouse dendritic cells , 1999, Journal of leukocyte biology.

[21]  R. Maldonado-López,et al.  Role of CD8α+ and CD8α− dendritic cells in the induction of primary immune responses in vivo , 1999, Journal of leukocyte biology.

[22]  Mamoru Ito,et al.  Interleukin 12-dependent interferon gamma production by CD8alpha+ lymphoid dendritic cells. , 1999 .

[23]  Antonio Lanzavecchia,et al.  Distinct patterns and kinetics of chemokine production regulate dendritic cell function , 1999, European journal of immunology.

[24]  G. Schuler,et al.  An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. , 1999, Journal of immunological methods.

[25]  R. Steinman,et al.  Efficient Presentation of Phagocytosed Cellular Fragments on the Major Histocompatibility Complex Class II Products of Dendritic Cells , 1998, The Journal of experimental medicine.

[26]  M. Hutchinson,et al.  Rate of Pregnancy-Related Relapse in Multiple Sclerosis , 1998 .

[27]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[28]  R. Steinman,et al.  Generation or large numbers of immature and mature dendritic cells from rat bone marrow cultures , 1998, European journal of immunology.

[29]  B. Pulendran,et al.  Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. , 1997, Journal of immunology.

[30]  R. Steinman,et al.  High Levels of a Major Histocompatibility Complex II–Self Peptide Complex on Dendritic Cells from the T Cell Areas of Lymph Nodes , 1997, The Journal of experimental medicine.

[31]  F. Sallusto,et al.  Origin, maturation and antigen presenting function of dendritic cells. , 1997, Current opinion in immunology.

[32]  A. Vandenbark,et al.  Male SJL mice do not relapse after induction of EAE with PLP 139–151 , 1996, Journal of neuroscience research.

[33]  V. Perry,et al.  The potential role of dendritic cells in immune-mediated inflammatory diseases in the central nervous system , 1996, Neuroscience.

[34]  S. Miller,et al.  Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis , 1995, The Journal of experimental medicine.

[35]  F. Sallusto,et al.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.

[36]  R. Steinman,et al.  Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor , 1992, The Journal of experimental medicine.

[37]  E. Sercarz,et al.  Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen , 1992, Nature.

[38]  P. Glynn,et al.  Lewis rat lymphoid dendritic cells can efficiently present homologous myelin basic protein to encephalitogenic lymphocytes , 1989, Journal of Neuroimmunology.

[39]  S. Poser,et al.  Activity of multiple sclerosis during pregnancy and puerperium , 1985, Annals of neurology.

[40]  C. Grossman.  Possible underlying mechanisms of sexual dimorphism in the immune response, fact and hypothesis. , 1989, Journal of steroid biochemistry.